CSU Knowledge Centre
How should the UAS7 be used in CSU?
Christian Vestergaard, Associate Professor in the Department of Dermatology at the University of Aarhus, Denmark answers the question, 'How should the UAS7 be used in chronic spontaneous urticaria?'.
Doctor Christian Vestergaard describes the Urticaria Activity Score system, which involves the assessment of wheals and pruritus, and discusses the use of this tool for assessing disease activity and treatment interventions to aid patient management decisions.
Christian Vestergaard
Associate Professor, Department of Dermatology, University of Aarhus, Denmark.
More FAQs
When a patient has been started on omalizumab, can you stop antihistamine treatment?
Werner Aberer, Professor of Dermatology and Chairman at the Department of Dermatology, Medical University of Graz, Austria answers the question 'When a patient has been started on omalizumab, can you stop antihistamine treatment?'.
Do IgE levels need to be measured before starting a patient with chronic spontaneous urticaria on omalizumab?
Karoline Krause, Assistant Professor of Dermatology at the Department of Dermatology and Allergy, Charité – Universitätsmedizin Berlin, Germany, is posed the question: 'Do IgE levels need to be measured before starting a patient with chronic spontaneous urticaria on omalizumab?'.
Can chronic spontaneous urticaria be treated during pregnancy?
Doctor Marta Ferrer of Clínica Universidad de Navarra, Pamplona, discusses how pregnancy affects treatment options for CSU, answering the question, 'Can chronic spontaneous urticaria be treated during pregnancy?'.
How to choose a third-line treatment in a patient who has not responded to antihistamine treatment.
Professor Ana Giménez-Arnau, Professor of Dermatology at the Hospital del Mar, Universitat Autònoma, Barcelona discusses how to choose a third-line treatment in a patient who has not responded to antihistamine treatment.
When should you stop treating a patient with CSU?
Professor Martin Metz of University Hospital Charité, Berlin discusses when to consider withdrawing treatment in those who no longer have symptoms, answering the question 'When should you stop treating a patient with CSU?'.
Are topical treatments such as topical corticosteroids recommended in chronic spontaneous urticaria?
Associate Professor Christian Vestergaard addresses the role of topical steroids in chronic spontaneous urticaria, answering the question 'Are topical treatments such as topical corticosteroids recommended in chronic spontaneous urticaria?'.
How do you choose which antihistamine to use in a newly diagnosed patient?
Professor Aberer of the University of Graz answers the question of which antihistamine to choose in a newly diagnosed patient with CSU, discussing the benefits of second-generation antihistamines and dosing strategies.
In a patient with new onset CSU, what investigations should be done?
Associate Professor Emek Kocatürk discusses the investigations that should be carried out when seeing a patient with new onset chronic spontaneous urticaria.
What laboratory tests do you investigate in chronic spontaneous urticaria to exclude other diagnoses?
Our expert, Associate Professor Emek Kocatürk, answers the question of what differential diagnoses to consider when confronted with a patient presenting with symptoms of CSU, explaining how to exclude these through a mixture of clinical and laboratory tests.
FAQs on the low-pseudoallergen diet.
Take a look at some of the frequently asked questions about the low-pseudoallergen diet, answered by our expert Josefine Grünhagen. Including the effects of pre-cooking meals and the use of raising agents in bread and eggs in cakes.
Are low-pseudoallergen diets useful in the extended diagnostic programme of CSU?
Josefine Grünhagen discusses the use of low-pseudoallergen diets in relation to patients with chronic spontaneous urticaria symptoms.
Alternatively login via
Related Learning Zones
Inflammatory Bowel Disease Knowledge Centre
Inflammatory bowel disease assessment tools
Cystic Fibrosis Knowledge Centre
Chronic Lymphocytic Leukaemia (CLL)
Back to epgonline.org